Global Generic Drugs Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Generic Drugs market size is predicted to grow from US$ 359240 million in 2025 to US$ 589660 million in 2031; it is expected to grow at a CAGR of 8.6% from 2025 to 2031.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.
North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.
LPI (LP Information)' newest research report, the “Generic Drugs Industry Forecast” looks at past sales and reviews total world Generic Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Generic Drugs sales for 2025 through 2031. With Generic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Generic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Generic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Generic Drugs market size is predicted to grow from US$ 359240 million in 2025 to US$ 589660 million in 2031; it is expected to grow at a CAGR of 8.6% from 2025 to 2031.
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.
North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.
LPI (LP Information)' newest research report, the “Generic Drugs Industry Forecast” looks at past sales and reviews total world Generic Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Generic Drugs sales for 2025 through 2031. With Generic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Generic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Generic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Prescription
- Non-Prescription Drugs
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Novartis - Sandoz
- Mylan
- Sun Pharmaceutical
- Aspen
- Fresenius Kabi
- Pfizer (Hospira)
- Sanofi
- Aurobindo
- Lupin
- Dr. Reddy's
- Apotex
- Cipla
- ENDO (Par Pharmaceutical)
- Stada Arzneimittel
- Krka Group
- Nichi-Iko Pharmaceutical
- Valeant
- Zydus Cadila
- Hikma
- Pharmaniaga Berhad
- Hovid Berhad
- Duopharma Biotech
- Kotra Pharma
- HOE Pharmaceutical
- Y.S.P. Industries
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Generic Drugs Market Size (2020-2031)
2.1.2 Generic Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Generic Drugs by Country/Region (2020, 2024 & 2031)
2.2 Generic Drugs Segment by Type
2.2.1 Prescription
2.2.2 Non-Prescription Drugs
2.3 Generic Drugs Market Size by Type
2.3.1 Generic Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Generic Drugs Market Size Market Share by Type (2020-2025)
2.4 Generic Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Generic Drugs Market Size by Application
2.5.1 Generic Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Generic Drugs Market Size Market Share by Application (2020-2025)
3 GENERIC DRUGS MARKET SIZE BY PLAYER
3.1 Generic Drugs Market Size Market Share by Player
3.1.1 Global Generic Drugs Revenue by Player (2020-2025)
3.1.2 Global Generic Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Generic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENERIC DRUGS BY REGION
4.1 Generic Drugs Market Size by Region (2020-2025)
4.2 Global Generic Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Generic Drugs Market Size Growth (2020-2025)
4.4 APAC Generic Drugs Market Size Growth (2020-2025)
4.5 Europe Generic Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Generic Drugs Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Generic Drugs Market Size by Country (2020-2025)
5.2 Americas Generic Drugs Market Size by Type (2020-2025)
5.3 Americas Generic Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Drugs Market Size by Region (2020-2025)
6.2 APAC Generic Drugs Market Size by Type (2020-2025)
6.3 APAC Generic Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Generic Drugs Market Size by Country (2020-2025)
7.2 Europe Generic Drugs Market Size by Type (2020-2025)
7.3 Europe Generic Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Generic Drugs by Region (2020-2025)
8.2 Middle East & Africa Generic Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Generic Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENERIC DRUGS MARKET FORECAST
10.1 Global Generic Drugs Forecast by Region (2026-2031)
10.1.1 Global Generic Drugs Forecast by Region (2026-2031)
10.1.2 Americas Generic Drugs Forecast
10.1.3 APAC Generic Drugs Forecast
10.1.4 Europe Generic Drugs Forecast
10.1.5 Middle East & Africa Generic Drugs Forecast
10.2 Americas Generic Drugs Forecast by Country (2026-2031)
10.2.1 United States Market Generic Drugs Forecast
10.2.2 Canada Market Generic Drugs Forecast
10.2.3 Mexico Market Generic Drugs Forecast
10.2.4 Brazil Market Generic Drugs Forecast
10.3 APAC Generic Drugs Forecast by Region (2026-2031)
10.3.1 China Generic Drugs Market Forecast
10.3.2 Japan Market Generic Drugs Forecast
10.3.3 Korea Market Generic Drugs Forecast
10.3.4 Southeast Asia Market Generic Drugs Forecast
10.3.5 India Market Generic Drugs Forecast
10.3.6 Australia Market Generic Drugs Forecast
10.4 Europe Generic Drugs Forecast by Country (2026-2031)
10.4.1 Germany Market Generic Drugs Forecast
10.4.2 France Market Generic Drugs Forecast
10.4.3 UK Market Generic Drugs Forecast
10.4.4 Italy Market Generic Drugs Forecast
10.4.5 Russia Market Generic Drugs Forecast
10.5 Middle East & Africa Generic Drugs Forecast by Region (2026-2031)
10.5.1 Egypt Market Generic Drugs Forecast
10.5.2 South Africa Market Generic Drugs Forecast
10.5.3 Israel Market Generic Drugs Forecast
10.5.4 Turkey Market Generic Drugs Forecast
10.6 Global Generic Drugs Forecast by Type (2026-2031)
10.7 Global Generic Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Generic Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Generic Drugs Product Offered
11.1.3 Teva Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Information
11.2.2 Novartis - Sandoz Generic Drugs Product Offered
11.2.3 Novartis - Sandoz Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Novartis - Sandoz Main Business Overview
11.2.5 Novartis - Sandoz Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Generic Drugs Product Offered
11.3.3 Mylan Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Generic Drugs Product Offered
11.4.3 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Aspen
11.5.1 Aspen Company Information
11.5.2 Aspen Generic Drugs Product Offered
11.5.3 Aspen Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Aspen Main Business Overview
11.5.5 Aspen Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Generic Drugs Product Offered
11.6.3 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Information
11.7.2 Pfizer (Hospira) Generic Drugs Product Offered
11.7.3 Pfizer (Hospira) Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pfizer (Hospira) Main Business Overview
11.7.5 Pfizer (Hospira) Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Generic Drugs Product Offered
11.8.3 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Aurobindo
11.9.1 Aurobindo Company Information
11.9.2 Aurobindo Generic Drugs Product Offered
11.9.3 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Aurobindo Main Business Overview
11.9.5 Aurobindo Latest Developments
11.10 Lupin
11.10.1 Lupin Company Information
11.10.2 Lupin Generic Drugs Product Offered
11.10.3 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lupin Main Business Overview
11.10.5 Lupin Latest Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Information
11.11.2 Dr. Reddy's Generic Drugs Product Offered
11.11.3 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Dr. Reddy's Main Business Overview
11.11.5 Dr. Reddy's Latest Developments
11.12 Apotex
11.12.1 Apotex Company Information
11.12.2 Apotex Generic Drugs Product Offered
11.12.3 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Apotex Main Business Overview
11.12.5 Apotex Latest Developments
11.13 Cipla
11.13.1 Cipla Company Information
11.13.2 Cipla Generic Drugs Product Offered
11.13.3 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Cipla Main Business Overview
11.13.5 Cipla Latest Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Information
11.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Offered
11.14.3 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 ENDO (Par Pharmaceutical) Main Business Overview
11.14.5 ENDO (Par Pharmaceutical) Latest Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Information
11.15.2 Stada Arzneimittel Generic Drugs Product Offered
11.15.3 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Stada Arzneimittel Main Business Overview
11.15.5 Stada Arzneimittel Latest Developments
11.16 Krka Group
11.16.1 Krka Group Company Information
11.16.2 Krka Group Generic Drugs Product Offered
11.16.3 Krka Group Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Krka Group Main Business Overview
11.16.5 Krka Group Latest Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Information
11.17.2 Nichi-Iko Pharmaceutical Generic Drugs Product Offered
11.17.3 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Nichi-Iko Pharmaceutical Main Business Overview
11.17.5 Nichi-Iko Pharmaceutical Latest Developments
11.18 Valeant
11.18.1 Valeant Company Information
11.18.2 Valeant Generic Drugs Product Offered
11.18.3 Valeant Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Valeant Main Business Overview
11.18.5 Valeant Latest Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Information
11.19.2 Zydus Cadila Generic Drugs Product Offered
11.19.3 Zydus Cadila Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Zydus Cadila Main Business Overview
11.19.5 Zydus Cadila Latest Developments
11.20 Hikma
11.20.1 Hikma Company Information
11.20.2 Hikma Generic Drugs Product Offered
11.20.3 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Hikma Main Business Overview
11.20.5 Hikma Latest Developments
11.21 Pharmaniaga Berhad
11.21.1 Pharmaniaga Berhad Company Information
11.21.2 Pharmaniaga Berhad Generic Drugs Product Offered
11.21.3 Pharmaniaga Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Pharmaniaga Berhad Main Business Overview
11.21.5 Pharmaniaga Berhad Latest Developments
11.22 Hovid Berhad
11.22.1 Hovid Berhad Company Information
11.22.2 Hovid Berhad Generic Drugs Product Offered
11.22.3 Hovid Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Hovid Berhad Main Business Overview
11.22.5 Hovid Berhad Latest Developments
11.23 Duopharma Biotech
11.23.1 Duopharma Biotech Company Information
11.23.2 Duopharma Biotech Generic Drugs Product Offered
11.23.3 Duopharma Biotech Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Duopharma Biotech Main Business Overview
11.23.5 Duopharma Biotech Latest Developments
11.24 Kotra Pharma
11.24.1 Kotra Pharma Company Information
11.24.2 Kotra Pharma Generic Drugs Product Offered
11.24.3 Kotra Pharma Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Kotra Pharma Main Business Overview
11.24.5 Kotra Pharma Latest Developments
11.25 HOE Pharmaceutical
11.25.1 HOE Pharmaceutical Company Information
11.25.2 HOE Pharmaceutical Generic Drugs Product Offered
11.25.3 HOE Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 HOE Pharmaceutical Main Business Overview
11.25.5 HOE Pharmaceutical Latest Developments
11.26 Y.S.P. Industries
11.26.1 Y.S.P. Industries Company Information
11.26.2 Y.S.P. Industries Generic Drugs Product Offered
11.26.3 Y.S.P. Industries Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Y.S.P. Industries Main Business Overview
11.26.5 Y.S.P. Industries Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Generic Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Generic Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prescription
Table 4. Major Players of Non-Prescription Drugs
Table 5. Generic Drugs Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 7. Global Generic Drugs Market Size Market Share byType (2020-2025)
Table 8. Generic Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Generic Drugs Market Size Market Share by Application (2020-2025)
Table 11. Global Generic Drugs Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Generic Drugs Revenue Market Share by Player (2020-2025)
Table 13. Generic Drugs Key Players Head office and Products Offered
Table 14. Generic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Generic Drugs Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Generic Drugs Market Size Market Share by Region (2020-2025)
Table 19. Global Generic Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Generic Drugs Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Generic Drugs Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Generic Drugs Market Size Market Share by Country (2020-2025)
Table 23. Americas Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Generic Drugs Market Size Market Share byType (2020-2025)
Table 25. Americas Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Generic Drugs Market Size Market Share by Application (2020-2025)
Table 27. APAC Generic Drugs Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Generic Drugs Market Size Market Share by Region (2020-2025)
Table 29. APAC Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Generic Drugs Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Generic Drugs Market Size Market Share by Country (2020-2025)
Table 33. Europe Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Generic Drugs Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Generic Drugs
Table 39. Key Market Challenges & Risks of Generic Drugs
Table 40. Key IndustryTrends of Generic Drugs
Table 41. Global Generic Drugs Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Generic Drugs Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Generic Drugs Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Generic Drugs Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45.Teva Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 46.Teva Generic Drugs Product Offered
Table 47.Teva Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48.Teva Main Business
Table 49.Teva Latest Developments
Table 50. Novartis - Sandoz Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 51. Novartis - Sandoz Generic Drugs Product Offered
Table 52. Novartis - Sandoz Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novartis - Sandoz Main Business
Table 54. Novartis - Sandoz Latest Developments
Table 55. Mylan Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 56. Mylan Generic Drugs Product Offered
Table 57. Mylan Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Mylan Main Business
Table 59. Mylan Latest Developments
Table 60. Sun Pharmaceutical Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 61. Sun Pharmaceutical Generic Drugs Product Offered
Table 62. Sun Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sun Pharmaceutical Main Business
Table 64. Sun Pharmaceutical Latest Developments
Table 65. Aspen Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 66. Aspen Generic Drugs Product Offered
Table 67. Aspen Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Aspen Main Business
Table 69. Aspen Latest Developments
Table 70.Fresenius Kabi Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 71.Fresenius Kabi Generic Drugs Product Offered
Table 72.Fresenius Kabi Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.Fresenius Kabi Main Business
Table 74.Fresenius Kabi Latest Developments
Table 75. Pfizer (Hospira) Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 76. Pfizer (Hospira) Generic Drugs Product Offered
Table 77. Pfizer (Hospira) Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer (Hospira) Main Business
Table 79. Pfizer (Hospira) Latest Developments
Table 80. Sanofi Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 81. Sanofi Generic Drugs Product Offered
Table 82. Sanofi Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Sanofi Main Business
Table 84. Sanofi Latest Developments
Table 85. Aurobindo Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 86. Aurobindo Generic Drugs Product Offered
Table 87. Aurobindo Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Aurobindo Main Business
Table 89. Aurobindo Latest Developments
Table 90. Lupin Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 91. Lupin Generic Drugs Product Offered
Table 92. Lupin Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Lupin Main Business
Table 94. Lupin Latest Developments
Table 95. Dr. Reddy's Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 96. Dr. Reddy's Generic Drugs Product Offered
Table 97. Dr. Reddy's Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Dr. Reddy's Main Business
Table 99. Dr. Reddy's Latest Developments
Table 100. Apotex Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 101. Apotex Generic Drugs Product Offered
Table 102. Apotex Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Apotex Main Business
Table 104. Apotex Latest Developments
Table 105. Cipla Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 106. Cipla Generic Drugs Product Offered
Table 107. Cipla Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Cipla Main Business
Table 109. Cipla Latest Developments
Table 110. ENDO (Par Pharmaceutical) Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 111. ENDO (Par Pharmaceutical) Generic Drugs Product Offered
Table 112. ENDO (Par Pharmaceutical) Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. ENDO (Par Pharmaceutical) Main Business
Table 114. ENDO (Par Pharmaceutical) Latest Developments
Table 115. Stada Arzneimittel Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 116. Stada Arzneimittel Generic Drugs Product Offered
Table 117. Stada Arzneimittel Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Stada Arzneimittel Main Business
Table 119. Stada Arzneimittel Latest Developments
Table 120. Krka Group Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 121. Krka Group Generic Drugs Product Offered
Table 122. Krka Group Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Krka Group Main Business
Table 124. Krka Group Latest Developments
Table 125. Nichi-Iko Pharmaceutical Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 126. Nichi-Iko Pharmaceutical Generic Drugs Product Offered
Table 127. Nichi-Iko Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Nichi-Iko Pharmaceutical Main Business
Table 129. Nichi-Iko Pharmaceutical Latest Developments
Table 130. Valeant Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 131. Valeant Generic Drugs Product Offered
Table 132. Valeant Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Valeant Main Business
Table 134. Valeant Latest Developments
Table 135. Zydus Cadila Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 136. Zydus Cadila Generic Drugs Product Offered
Table 137. Zydus Cadila Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Zydus Cadila Main Business
Table 139. Zydus Cadila Latest Developments
Table 140. Hikma Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 141. Hikma Generic Drugs Product Offered
Table 142. Hikma Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Hikma Main Business
Table 144. Hikma Latest Developments
Table 145. Pharmaniaga Berhad Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 146. Pharmaniaga Berhad Generic Drugs Product Offered
Table 147. Pharmaniaga Berhad Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Pharmaniaga Berhad Main Business
Table 149. Pharmaniaga Berhad Latest Developments
Table 150. Hovid Berhad Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 151. Hovid Berhad Generic Drugs Product Offered
Table 152. Hovid Berhad Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. Hovid Berhad Main Business
Table 154. Hovid Berhad Latest Developments
Table 155. Duopharma Biotech Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 156. Duopharma Biotech Generic Drugs Product Offered
Table 157. Duopharma Biotech Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 158. Duopharma Biotech Main Business
Table 159. Duopharma Biotech Latest Developments
Table 160. Kotra Pharma Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 161. Kotra Pharma Generic Drugs Product Offered
Table 162. Kotra Pharma Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 163. Kotra Pharma Main Business
Table 164. Kotra Pharma Latest Developments
Table 165. HOE Pharmaceutical Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 166. HOE Pharmaceutical Generic Drugs Product Offered
Table 167. HOE Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 168. HOE Pharmaceutical Main Business
Table 169. HOE Pharmaceutical Latest Developments
Table 170. Y.S.P. Industries Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 171. Y.S.P. Industries Generic Drugs Product Offered
Table 172. Y.S.P. Industries Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 173. Y.S.P. Industries Main Business
Table 174. Y.S.P. Industries Latest Developments
LIST OFFIGURES
Figure 1. Generic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Generic Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Generic Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Generic Drugs Sales Market Share by Country/Region (2024)
Figure 8. Generic Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Generic Drugs Market Size Market Share byType in 2024
Figure 10. Generic Drugs in Hospital
Figure 11. Global Generic Drugs Market: Hospital (2020-2025) & ($ millions)
Figure 12. Generic Drugs in Clinic
Figure 13. Global Generic Drugs Market: Clinic (2020-2025) & ($ millions)
Figure 14. Generic Drugs in Others
Figure 15. Global Generic Drugs Market: Others (2020-2025) & ($ millions)
Figure 16. Global Generic Drugs Market Size Market Share by Application in 2024
Figure 17. Global Generic Drugs Revenue Market Share by Player in 2024
Figure 18. Global Generic Drugs Market Size Market Share by Region (2020-2025)
Figure 19. Americas Generic Drugs Market Size 2020-2025 ($ millions)
Figure 20. APAC Generic Drugs Market Size 2020-2025 ($ millions)
Figure 21. Europe Generic Drugs Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Generic Drugs Market Size 2020-2025 ($ millions)
Figure 23. Americas Generic Drugs Value Market Share by Country in 2024
Figure 24. United States Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Generic Drugs Market Size Market Share by Region in 2024
Figure 29. APAC Generic Drugs Market Size Market Share byType (2020-2025)
Figure 30. APAC Generic Drugs Market Size Market Share by Application (2020-2025)
Figure 31. China Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. India Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Generic Drugs Market Size Market Share by Country in 2024
Figure 38. Europe Generic Drugs Market Size Market Share byType (2020-2025)
Figure 39. Europe Generic Drugs Market Size Market Share by Application (2020-2025)
Figure 40. Germany Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41.France Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Generic Drugs Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Generic Drugs Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Generic Drugs Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Generic Drugs Market Size 2026-2031 ($ millions)
Figure 54. APAC Generic Drugs Market Size 2026-2031 ($ millions)
Figure 55. Europe Generic Drugs Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Generic Drugs Market Size 2026-2031 ($ millions)
Figure 57. United States Generic Drugs Market Size 2026-2031 ($ millions)
Figure 58. Canada Generic Drugs Market Size 2026-2031 ($ millions)
Figure 59. Mexico Generic Drugs Market Size 2026-2031 ($ millions)
Figure 60. Brazil Generic Drugs Market Size 2026-2031 ($ millions)
Figure 61. China Generic Drugs Market Size 2026-2031 ($ millions)
Figure 62. Japan Generic Drugs Market Size 2026-2031 ($ millions)
Figure 63. Korea Generic Drugs Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Generic Drugs Market Size 2026-2031 ($ millions)
Figure 65. India Generic Drugs Market Size 2026-2031 ($ millions)
Figure 66. Australia Generic Drugs Market Size 2026-2031 ($ millions)
Figure 67. Germany Generic Drugs Market Size 2026-2031 ($ millions)
Figure 68.France Generic Drugs Market Size 2026-2031 ($ millions)
Figure 69. UK Generic Drugs Market Size 2026-2031 ($ millions)
Figure 70. Italy Generic Drugs Market Size 2026-2031 ($ millions)
Figure 71. Russia Generic Drugs Market Size 2026-2031 ($ millions)
Figure 72. Egypt Generic Drugs Market Size 2026-2031 ($ millions)
Figure 73. South Africa Generic Drugs Market Size 2026-2031 ($ millions)
Figure 74. Israel Generic Drugs Market Size 2026-2031 ($ millions)
Figure 75.Turkey Generic Drugs Market Size 2026-2031 ($ millions)
Figure 76. Global Generic Drugs Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Generic Drugs Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Generic Drugs Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Generic Drugs Market Size (2020-2031)
2.1.2 Generic Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Generic Drugs by Country/Region (2020, 2024 & 2031)
2.2 Generic Drugs Segment by Type
2.2.1 Prescription
2.2.2 Non-Prescription Drugs
2.3 Generic Drugs Market Size by Type
2.3.1 Generic Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Generic Drugs Market Size Market Share by Type (2020-2025)
2.4 Generic Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Generic Drugs Market Size by Application
2.5.1 Generic Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Generic Drugs Market Size Market Share by Application (2020-2025)
3 GENERIC DRUGS MARKET SIZE BY PLAYER
3.1 Generic Drugs Market Size Market Share by Player
3.1.1 Global Generic Drugs Revenue by Player (2020-2025)
3.1.2 Global Generic Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Generic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENERIC DRUGS BY REGION
4.1 Generic Drugs Market Size by Region (2020-2025)
4.2 Global Generic Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Generic Drugs Market Size Growth (2020-2025)
4.4 APAC Generic Drugs Market Size Growth (2020-2025)
4.5 Europe Generic Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Generic Drugs Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Generic Drugs Market Size by Country (2020-2025)
5.2 Americas Generic Drugs Market Size by Type (2020-2025)
5.3 Americas Generic Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Drugs Market Size by Region (2020-2025)
6.2 APAC Generic Drugs Market Size by Type (2020-2025)
6.3 APAC Generic Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Generic Drugs Market Size by Country (2020-2025)
7.2 Europe Generic Drugs Market Size by Type (2020-2025)
7.3 Europe Generic Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Generic Drugs by Region (2020-2025)
8.2 Middle East & Africa Generic Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Generic Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENERIC DRUGS MARKET FORECAST
10.1 Global Generic Drugs Forecast by Region (2026-2031)
10.1.1 Global Generic Drugs Forecast by Region (2026-2031)
10.1.2 Americas Generic Drugs Forecast
10.1.3 APAC Generic Drugs Forecast
10.1.4 Europe Generic Drugs Forecast
10.1.5 Middle East & Africa Generic Drugs Forecast
10.2 Americas Generic Drugs Forecast by Country (2026-2031)
10.2.1 United States Market Generic Drugs Forecast
10.2.2 Canada Market Generic Drugs Forecast
10.2.3 Mexico Market Generic Drugs Forecast
10.2.4 Brazil Market Generic Drugs Forecast
10.3 APAC Generic Drugs Forecast by Region (2026-2031)
10.3.1 China Generic Drugs Market Forecast
10.3.2 Japan Market Generic Drugs Forecast
10.3.3 Korea Market Generic Drugs Forecast
10.3.4 Southeast Asia Market Generic Drugs Forecast
10.3.5 India Market Generic Drugs Forecast
10.3.6 Australia Market Generic Drugs Forecast
10.4 Europe Generic Drugs Forecast by Country (2026-2031)
10.4.1 Germany Market Generic Drugs Forecast
10.4.2 France Market Generic Drugs Forecast
10.4.3 UK Market Generic Drugs Forecast
10.4.4 Italy Market Generic Drugs Forecast
10.4.5 Russia Market Generic Drugs Forecast
10.5 Middle East & Africa Generic Drugs Forecast by Region (2026-2031)
10.5.1 Egypt Market Generic Drugs Forecast
10.5.2 South Africa Market Generic Drugs Forecast
10.5.3 Israel Market Generic Drugs Forecast
10.5.4 Turkey Market Generic Drugs Forecast
10.6 Global Generic Drugs Forecast by Type (2026-2031)
10.7 Global Generic Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Generic Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Generic Drugs Product Offered
11.1.3 Teva Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Information
11.2.2 Novartis - Sandoz Generic Drugs Product Offered
11.2.3 Novartis - Sandoz Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Novartis - Sandoz Main Business Overview
11.2.5 Novartis - Sandoz Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Generic Drugs Product Offered
11.3.3 Mylan Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Generic Drugs Product Offered
11.4.3 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Aspen
11.5.1 Aspen Company Information
11.5.2 Aspen Generic Drugs Product Offered
11.5.3 Aspen Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Aspen Main Business Overview
11.5.5 Aspen Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Generic Drugs Product Offered
11.6.3 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Information
11.7.2 Pfizer (Hospira) Generic Drugs Product Offered
11.7.3 Pfizer (Hospira) Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pfizer (Hospira) Main Business Overview
11.7.5 Pfizer (Hospira) Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Generic Drugs Product Offered
11.8.3 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Aurobindo
11.9.1 Aurobindo Company Information
11.9.2 Aurobindo Generic Drugs Product Offered
11.9.3 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Aurobindo Main Business Overview
11.9.5 Aurobindo Latest Developments
11.10 Lupin
11.10.1 Lupin Company Information
11.10.2 Lupin Generic Drugs Product Offered
11.10.3 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lupin Main Business Overview
11.10.5 Lupin Latest Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Information
11.11.2 Dr. Reddy's Generic Drugs Product Offered
11.11.3 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Dr. Reddy's Main Business Overview
11.11.5 Dr. Reddy's Latest Developments
11.12 Apotex
11.12.1 Apotex Company Information
11.12.2 Apotex Generic Drugs Product Offered
11.12.3 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Apotex Main Business Overview
11.12.5 Apotex Latest Developments
11.13 Cipla
11.13.1 Cipla Company Information
11.13.2 Cipla Generic Drugs Product Offered
11.13.3 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Cipla Main Business Overview
11.13.5 Cipla Latest Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Information
11.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Offered
11.14.3 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 ENDO (Par Pharmaceutical) Main Business Overview
11.14.5 ENDO (Par Pharmaceutical) Latest Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Information
11.15.2 Stada Arzneimittel Generic Drugs Product Offered
11.15.3 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Stada Arzneimittel Main Business Overview
11.15.5 Stada Arzneimittel Latest Developments
11.16 Krka Group
11.16.1 Krka Group Company Information
11.16.2 Krka Group Generic Drugs Product Offered
11.16.3 Krka Group Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Krka Group Main Business Overview
11.16.5 Krka Group Latest Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Information
11.17.2 Nichi-Iko Pharmaceutical Generic Drugs Product Offered
11.17.3 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Nichi-Iko Pharmaceutical Main Business Overview
11.17.5 Nichi-Iko Pharmaceutical Latest Developments
11.18 Valeant
11.18.1 Valeant Company Information
11.18.2 Valeant Generic Drugs Product Offered
11.18.3 Valeant Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Valeant Main Business Overview
11.18.5 Valeant Latest Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Information
11.19.2 Zydus Cadila Generic Drugs Product Offered
11.19.3 Zydus Cadila Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Zydus Cadila Main Business Overview
11.19.5 Zydus Cadila Latest Developments
11.20 Hikma
11.20.1 Hikma Company Information
11.20.2 Hikma Generic Drugs Product Offered
11.20.3 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Hikma Main Business Overview
11.20.5 Hikma Latest Developments
11.21 Pharmaniaga Berhad
11.21.1 Pharmaniaga Berhad Company Information
11.21.2 Pharmaniaga Berhad Generic Drugs Product Offered
11.21.3 Pharmaniaga Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Pharmaniaga Berhad Main Business Overview
11.21.5 Pharmaniaga Berhad Latest Developments
11.22 Hovid Berhad
11.22.1 Hovid Berhad Company Information
11.22.2 Hovid Berhad Generic Drugs Product Offered
11.22.3 Hovid Berhad Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Hovid Berhad Main Business Overview
11.22.5 Hovid Berhad Latest Developments
11.23 Duopharma Biotech
11.23.1 Duopharma Biotech Company Information
11.23.2 Duopharma Biotech Generic Drugs Product Offered
11.23.3 Duopharma Biotech Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Duopharma Biotech Main Business Overview
11.23.5 Duopharma Biotech Latest Developments
11.24 Kotra Pharma
11.24.1 Kotra Pharma Company Information
11.24.2 Kotra Pharma Generic Drugs Product Offered
11.24.3 Kotra Pharma Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Kotra Pharma Main Business Overview
11.24.5 Kotra Pharma Latest Developments
11.25 HOE Pharmaceutical
11.25.1 HOE Pharmaceutical Company Information
11.25.2 HOE Pharmaceutical Generic Drugs Product Offered
11.25.3 HOE Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 HOE Pharmaceutical Main Business Overview
11.25.5 HOE Pharmaceutical Latest Developments
11.26 Y.S.P. Industries
11.26.1 Y.S.P. Industries Company Information
11.26.2 Y.S.P. Industries Generic Drugs Product Offered
11.26.3 Y.S.P. Industries Generic Drugs Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Y.S.P. Industries Main Business Overview
11.26.5 Y.S.P. Industries Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Generic Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Generic Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prescription
Table 4. Major Players of Non-Prescription Drugs
Table 5. Generic Drugs Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 7. Global Generic Drugs Market Size Market Share byType (2020-2025)
Table 8. Generic Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Generic Drugs Market Size Market Share by Application (2020-2025)
Table 11. Global Generic Drugs Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Generic Drugs Revenue Market Share by Player (2020-2025)
Table 13. Generic Drugs Key Players Head office and Products Offered
Table 14. Generic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Generic Drugs Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Generic Drugs Market Size Market Share by Region (2020-2025)
Table 19. Global Generic Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Generic Drugs Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Generic Drugs Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Generic Drugs Market Size Market Share by Country (2020-2025)
Table 23. Americas Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Generic Drugs Market Size Market Share byType (2020-2025)
Table 25. Americas Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Generic Drugs Market Size Market Share by Application (2020-2025)
Table 27. APAC Generic Drugs Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Generic Drugs Market Size Market Share by Region (2020-2025)
Table 29. APAC Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Generic Drugs Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Generic Drugs Market Size Market Share by Country (2020-2025)
Table 33. Europe Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Generic Drugs Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Generic Drugs Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Generic Drugs Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Generic Drugs
Table 39. Key Market Challenges & Risks of Generic Drugs
Table 40. Key IndustryTrends of Generic Drugs
Table 41. Global Generic Drugs Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Generic Drugs Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Generic Drugs Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Generic Drugs Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45.Teva Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 46.Teva Generic Drugs Product Offered
Table 47.Teva Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48.Teva Main Business
Table 49.Teva Latest Developments
Table 50. Novartis - Sandoz Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 51. Novartis - Sandoz Generic Drugs Product Offered
Table 52. Novartis - Sandoz Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novartis - Sandoz Main Business
Table 54. Novartis - Sandoz Latest Developments
Table 55. Mylan Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 56. Mylan Generic Drugs Product Offered
Table 57. Mylan Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Mylan Main Business
Table 59. Mylan Latest Developments
Table 60. Sun Pharmaceutical Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 61. Sun Pharmaceutical Generic Drugs Product Offered
Table 62. Sun Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sun Pharmaceutical Main Business
Table 64. Sun Pharmaceutical Latest Developments
Table 65. Aspen Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 66. Aspen Generic Drugs Product Offered
Table 67. Aspen Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Aspen Main Business
Table 69. Aspen Latest Developments
Table 70.Fresenius Kabi Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 71.Fresenius Kabi Generic Drugs Product Offered
Table 72.Fresenius Kabi Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.Fresenius Kabi Main Business
Table 74.Fresenius Kabi Latest Developments
Table 75. Pfizer (Hospira) Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 76. Pfizer (Hospira) Generic Drugs Product Offered
Table 77. Pfizer (Hospira) Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer (Hospira) Main Business
Table 79. Pfizer (Hospira) Latest Developments
Table 80. Sanofi Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 81. Sanofi Generic Drugs Product Offered
Table 82. Sanofi Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Sanofi Main Business
Table 84. Sanofi Latest Developments
Table 85. Aurobindo Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 86. Aurobindo Generic Drugs Product Offered
Table 87. Aurobindo Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Aurobindo Main Business
Table 89. Aurobindo Latest Developments
Table 90. Lupin Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 91. Lupin Generic Drugs Product Offered
Table 92. Lupin Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Lupin Main Business
Table 94. Lupin Latest Developments
Table 95. Dr. Reddy's Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 96. Dr. Reddy's Generic Drugs Product Offered
Table 97. Dr. Reddy's Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Dr. Reddy's Main Business
Table 99. Dr. Reddy's Latest Developments
Table 100. Apotex Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 101. Apotex Generic Drugs Product Offered
Table 102. Apotex Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Apotex Main Business
Table 104. Apotex Latest Developments
Table 105. Cipla Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 106. Cipla Generic Drugs Product Offered
Table 107. Cipla Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Cipla Main Business
Table 109. Cipla Latest Developments
Table 110. ENDO (Par Pharmaceutical) Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 111. ENDO (Par Pharmaceutical) Generic Drugs Product Offered
Table 112. ENDO (Par Pharmaceutical) Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. ENDO (Par Pharmaceutical) Main Business
Table 114. ENDO (Par Pharmaceutical) Latest Developments
Table 115. Stada Arzneimittel Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 116. Stada Arzneimittel Generic Drugs Product Offered
Table 117. Stada Arzneimittel Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Stada Arzneimittel Main Business
Table 119. Stada Arzneimittel Latest Developments
Table 120. Krka Group Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 121. Krka Group Generic Drugs Product Offered
Table 122. Krka Group Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Krka Group Main Business
Table 124. Krka Group Latest Developments
Table 125. Nichi-Iko Pharmaceutical Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 126. Nichi-Iko Pharmaceutical Generic Drugs Product Offered
Table 127. Nichi-Iko Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Nichi-Iko Pharmaceutical Main Business
Table 129. Nichi-Iko Pharmaceutical Latest Developments
Table 130. Valeant Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 131. Valeant Generic Drugs Product Offered
Table 132. Valeant Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Valeant Main Business
Table 134. Valeant Latest Developments
Table 135. Zydus Cadila Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 136. Zydus Cadila Generic Drugs Product Offered
Table 137. Zydus Cadila Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Zydus Cadila Main Business
Table 139. Zydus Cadila Latest Developments
Table 140. Hikma Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 141. Hikma Generic Drugs Product Offered
Table 142. Hikma Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Hikma Main Business
Table 144. Hikma Latest Developments
Table 145. Pharmaniaga Berhad Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 146. Pharmaniaga Berhad Generic Drugs Product Offered
Table 147. Pharmaniaga Berhad Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Pharmaniaga Berhad Main Business
Table 149. Pharmaniaga Berhad Latest Developments
Table 150. Hovid Berhad Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 151. Hovid Berhad Generic Drugs Product Offered
Table 152. Hovid Berhad Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. Hovid Berhad Main Business
Table 154. Hovid Berhad Latest Developments
Table 155. Duopharma Biotech Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 156. Duopharma Biotech Generic Drugs Product Offered
Table 157. Duopharma Biotech Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 158. Duopharma Biotech Main Business
Table 159. Duopharma Biotech Latest Developments
Table 160. Kotra Pharma Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 161. Kotra Pharma Generic Drugs Product Offered
Table 162. Kotra Pharma Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 163. Kotra Pharma Main Business
Table 164. Kotra Pharma Latest Developments
Table 165. HOE Pharmaceutical Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 166. HOE Pharmaceutical Generic Drugs Product Offered
Table 167. HOE Pharmaceutical Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 168. HOE Pharmaceutical Main Business
Table 169. HOE Pharmaceutical Latest Developments
Table 170. Y.S.P. Industries Details, CompanyType, Generic Drugs Area Served and Its Competitors
Table 171. Y.S.P. Industries Generic Drugs Product Offered
Table 172. Y.S.P. Industries Generic Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 173. Y.S.P. Industries Main Business
Table 174. Y.S.P. Industries Latest Developments
LIST OFFIGURES
Figure 1. Generic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Generic Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Generic Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Generic Drugs Sales Market Share by Country/Region (2024)
Figure 8. Generic Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Generic Drugs Market Size Market Share byType in 2024
Figure 10. Generic Drugs in Hospital
Figure 11. Global Generic Drugs Market: Hospital (2020-2025) & ($ millions)
Figure 12. Generic Drugs in Clinic
Figure 13. Global Generic Drugs Market: Clinic (2020-2025) & ($ millions)
Figure 14. Generic Drugs in Others
Figure 15. Global Generic Drugs Market: Others (2020-2025) & ($ millions)
Figure 16. Global Generic Drugs Market Size Market Share by Application in 2024
Figure 17. Global Generic Drugs Revenue Market Share by Player in 2024
Figure 18. Global Generic Drugs Market Size Market Share by Region (2020-2025)
Figure 19. Americas Generic Drugs Market Size 2020-2025 ($ millions)
Figure 20. APAC Generic Drugs Market Size 2020-2025 ($ millions)
Figure 21. Europe Generic Drugs Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Generic Drugs Market Size 2020-2025 ($ millions)
Figure 23. Americas Generic Drugs Value Market Share by Country in 2024
Figure 24. United States Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Generic Drugs Market Size Market Share by Region in 2024
Figure 29. APAC Generic Drugs Market Size Market Share byType (2020-2025)
Figure 30. APAC Generic Drugs Market Size Market Share by Application (2020-2025)
Figure 31. China Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. India Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Generic Drugs Market Size Market Share by Country in 2024
Figure 38. Europe Generic Drugs Market Size Market Share byType (2020-2025)
Figure 39. Europe Generic Drugs Market Size Market Share by Application (2020-2025)
Figure 40. Germany Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41.France Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Generic Drugs Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Generic Drugs Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Generic Drugs Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Generic Drugs Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Generic Drugs Market Size 2026-2031 ($ millions)
Figure 54. APAC Generic Drugs Market Size 2026-2031 ($ millions)
Figure 55. Europe Generic Drugs Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Generic Drugs Market Size 2026-2031 ($ millions)
Figure 57. United States Generic Drugs Market Size 2026-2031 ($ millions)
Figure 58. Canada Generic Drugs Market Size 2026-2031 ($ millions)
Figure 59. Mexico Generic Drugs Market Size 2026-2031 ($ millions)
Figure 60. Brazil Generic Drugs Market Size 2026-2031 ($ millions)
Figure 61. China Generic Drugs Market Size 2026-2031 ($ millions)
Figure 62. Japan Generic Drugs Market Size 2026-2031 ($ millions)
Figure 63. Korea Generic Drugs Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Generic Drugs Market Size 2026-2031 ($ millions)
Figure 65. India Generic Drugs Market Size 2026-2031 ($ millions)
Figure 66. Australia Generic Drugs Market Size 2026-2031 ($ millions)
Figure 67. Germany Generic Drugs Market Size 2026-2031 ($ millions)
Figure 68.France Generic Drugs Market Size 2026-2031 ($ millions)
Figure 69. UK Generic Drugs Market Size 2026-2031 ($ millions)
Figure 70. Italy Generic Drugs Market Size 2026-2031 ($ millions)
Figure 71. Russia Generic Drugs Market Size 2026-2031 ($ millions)
Figure 72. Egypt Generic Drugs Market Size 2026-2031 ($ millions)
Figure 73. South Africa Generic Drugs Market Size 2026-2031 ($ millions)
Figure 74. Israel Generic Drugs Market Size 2026-2031 ($ millions)
Figure 75.Turkey Generic Drugs Market Size 2026-2031 ($ millions)
Figure 76. Global Generic Drugs Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Generic Drugs Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Generic Drugs Market Size 2026-2031 ($ millions)
More Publications
Global Capsaicin Patches Market Growth 2023-2029
US$ 3,660.00
March 2023
93 pages
Global Lung Simulators Market Growth 2023-2029
US$ 3,660.00
March 2023
92 pages
Global J-Shape Medical Guide Wire Market Growth 2023-2029
US$ 3,660.00
March 2023
123 pages
Global Surgical Video Recording System Market Growth 2024-2030
US$ 3,660.00
December 2024
112 pages
